Yantai, Shandong Province-based Chinese drug-maker Luye Pharma Group Ltd., backed by Chinese private equity investors, has agreed to acquire the remaining 42.02% stake of Beijing Jialin Pharmaceutical Co., Ltd. it doesn't already own, according to a regulatory filing submitted on October 24. Luye Pharma, with shareholders including CDH Investments, CITIC Private Equity and New Horizon […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.